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Mechanism of decreased vascular response to angiotensin II in renal
vascular hypertension. Compared to many forms of hypertension,
vascular reactivity to angiotensin II (All) is decreased in the early phase
of two—kidney, one clip (2-K, IC) renovascular hypertension (RVH).
To determine the role of the All receptor, we examined vascular
responsiveness and '251-AII binding to mesenteric artery membrane
fractions after three weeks of 2-K, lC RVH. Systolic blood pressure
was 165 8 in RVH and 105 4mm Hg in controls, P < 0.001. Plasma
renin activity was 4.2 0.6 in RVH and 1.4 0.5 ng AL/mt/hr in
controls, P < .001. The pressor response to exogenous All was reduced
by 40% in RVH. Since administration of a single dose of converting
enzyme inhibitor (CEI) did not normalize the response to exogenous
All, the decreased reactivity was not caused by receptor occupancy.
'251A11 binding to mesenteric arteries was equal to or greater in RVH
than controls at all concentrations of All. Scatchard analysis revealed
an increase in the total number of binding sites (BMAX): 140.8 6.3 in
RVH versus 91.7 6.5 fmol/mg in controls, P < 0.01, while the
apparent dissociation constant was unchanged. To determine if the
increase in circulating All caused these binding alterations, rats were
either 1) treated with CEI for three days; or 2) unilaterally nephrecto-
mized. Both of these manipulations reversed the decrease in vascular
responsiveness as well as the increase in receptor number (BMAX = 136
13.4 in RVH vs. 94 9.4 fmol/mg in RVH + nephrectomy, P < 0.05).
We conclude that a post-receptor defect induced by increased circulat-
ing All mediated the decreased vascular response to All in early 2-K,
IC RVH.
A decreased pressor response to exogenous angiotensin II
(All) occurs in a variety of clinical states associated with
activation of the renin angiotensin system [1—8]. Pressor
hyporesponsiveness to All also occurs in the renin dependent
phase of 2-kidney, 1 clip renovascular hypertension (2-K, 1C
RVH) in the rat [9, 101. Theoretically, vascular hyporesponsive-
ness could be caused by a decrease in binding of All to its
putative membrane receptor as a consequence of a decrease in
the total number of binding sites or of a decrease in binding
affinity. Alternatively, there could be an abnormality in an
intracellular step in smooth muscle contraction distal to the
interaction of All with its putative receptor [111.
Since All levels are increased in the renin dependent phase of
2-K, 1C RVH, Marks, et al have suggested that the decreased
pressor response to exogenous All is the result of decreased
receptor availability caused by receptor occupancy with high
levels of endogenous All [9, 101. However, in other states
associated with increased endogenous All and vascular
hyporesponsiveness, changes in both receptor binding and
postreceptor abnormalities have been reported. For example,
both sodium and potassium depletion are associated with an
increase in endogenous All and vascular hyporesponsiveness
to exogenous All [3—8]. The vascular abnormalities are associ-
ated with decreased All binding in sodium depletion [12, 131. In
potassium depletion All binding is increased and there is a
post-receptor abnormality [14].
The purpose of the present study was to determine whether
the vascular hyporesponsiveness to exogenous All character-
istic of the renin dependent phase of 2-K, 1C RVH was




Male Sprague—Dawley rats weighing 175 to 200 g (Sasco
Laboratories, Omaha, Nebraska, USA) were utilized for study.
Two kidney, lC RVH was produced by placing a 0.20 or 0.23
mm (internal diameter) silver clip on the left renal artery. After
recovering from surgery animals were allowed free access to
standard rat chow and tap water. Systolic blood pressure (SBP)
was measured weekly with a tail cuff plethysmographic tech-
nique (Narco Biosystems, Houston, Texas, USA) and recorded
on a polygraph (Gilson Medical Electronics Inc Middleton,
Wisconsin, USA). Studies were performed on animals two to
three weeks after induction of hypertension. Animals were
considered hypertensive if the SBP exceeded 150 mm Hg.
Control animals were either unoperated, age and weight—
matched normotensive rats, or animals which had been oper-
ated but had a SBP <115 mm Hg and whose kidneys appeared
normal in association with displacement of the renal artery clip
at the time of necropsy. Since the two control groups did not
differ statistically in blood pressure, weight, plasma renin
activity, or plasma aldosterone, the results from studies using
either of the control groups were pooled for statistical analysis.
Control animals for vascular reactivity and All receptor binding
studies were unoperated, age and weight—matched normoten-
sive rats.
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Vascular reactivity
Animals were anesthetized with ether, and polyethylene
catheters (PE 50) were placed in the femoral artery and vein for
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direct arterial pressure monitoring and drug administration,
respectively. During surgery (7 to 10 minutes), rats were given
volume replacement of 0.5% body weight with 0.9% NaCI.
After surgery animals were placed in restraining cages and
allowed to recover in a quiet room for a minimum of 60 minutes
before the initiation of any further protocol.
Pressor response studies were performed by administering an
intravenous bolus of angiotensin II (Hypertension, Ciba—Geigy,
Basel, Switzerland) in doses of 12.5, 25, 50, and 100 ng to ten
hypertensive and eleven control animals. In additional animals
norepinephrine (levarterenol bitartrate, Sterling Drug, New
York, USA) in doses of 50, 100, 200, 400 ng was administered
to five hypertensive and five control animals. Stock solutions
were made monthly and final dilutions prepared daily by using
5% dextrose in water (D5W) so that the volume of injectate was
no more than 0.1 ml per dose. Each drug bolus was followed by
injection of 0.2 ml D5W to flush the venous catheter. Mean
arterial pressure (MAP) was measured with a Bell and Howell
pressure transducer (type 4-327-I, Bell and Howell Co.,
Pasadena, California, USA) and recorded on a polygraph.
Preliminary experiments showed that the rise in pressure after
injection of 0.3 ml D5W was less than 3 mm Hg in both
normotensive and hypertensive animals. After MAP had re-
turned to baseline (2 to 3 minutes) a period of 10 minutes was
allowed before the next dose of pressor agent. Preliminary
studies demonstrated reproducible pressor response in individ-
ual animals when repeated up to four times.
To determine whether the decrease in angiotensin II vascular
reactivity seen in 2-K, 1 C RVH was due to receptor occupancy
by sustained elevation of endogenous All levels, the pressor
response to exogenous All was determined after one dose of
converting enzyme inhibitor (CEI) (N = 8) or blank (N = 6).
Captopril (SQ 14225, E. R. Squibb and Sons, Princeton, New
Jersey, USA) was given as a 25 mg/kg intravenous bolus. One
hour later the pressor response to All was determined using the
previously described protocol. The adequacy of converting
enzyme inhibition was ascertained by determining the pressor
response to 50 ng of angiotensin I (Al) before the administration
of captopril and 10 mm after the last dose of All. All animals
had a decrease in pressor response to Al of at least 85%.
The pressor response to exogenous All was also determined
after sustained converting enzyme inhibition. For these studies
blank (N 5) or captopril (50 mg/kg bid) (N = 4) was
administered intraperitoneally for three days. Two hours after
the last dose of captopril, pressor dose response curves were
performed. In preliminary studies we determined that this
protocol resulted in an 85% reduction in the pressor response to
A!.
In additional studies, rats with RVH (SBP >150 mm Hg)
underwent unilateral removal of the clipped left kidney or sham
nephrectomy. Following recovery from surgery animals were
allowed free access to food and water and the pressor response
to All was determined after 24 hours.
Plasma determinations
Animals were prepared as for vascular reactivity studies. One
hour after recovery from anesthesia, arterial pressure was
recorded and blood was withdrawn rapidly from the femoral
artery and placed in chilled tubes for determination of Na, K,
plasma renin activity (PRA) and aldosterone. The blood was
immediately centrifuged at 4°C. The plasma was then decanted
and stored at —20°C until it was analyzed.
Plasma Na and K were measured with an IL 343 Flame
Photometer (Instrumentation Laboratories, Inc., Lexington,
Massachusetts, USA). PRA [15] and plasma aldosterone [16]
were measured by RIA.
Receptor binding studies
Preparation of tissue. Studies of receptor binding of angio-
tensin II were performed using mesenteric artery smooth mus-
cle particles. Small intestines with attached mesenteries were
removed en bloc from control or hypertensive rats and placed in
iced 0.25 M sucrose. Using methods previously described, [14]
the intestines were placed on a piece of filter paper moistened
with 0.25 M sucrose in a glass petri dish atop ice. The mesen-
teric arteries and branches were bluntly dissected away from
veins and bowel by using a rubber policeman and fine forceps.
Adherent fat was removed from the arteries with a loose fitting,
Potter—Elvehjem mechanical homogenizer. Pooled tissue from
three or four rats was then suspended in 20 ml 0.25 M sucrose,
minced with a fine scissors, homogenized for 10 seconds twice
(Polytron model PT lOST, Brinkman Instruments, Inc.,
Westbury, New York, USA), and sedimented at 1000 x g for 10
minutes at 4°C. The supernatant was centrifuged at 100,000 x g
for 35 minutes. The resulting pellet, a fraction rich in plasma
membrane was resuspended in 1.5 ml Tris-HC1 with a
Potter—Elvehjem homogenizer.
Receptor binding. All experiments were performed within
three hours of removal of tissue and on each day, both control
and experimental animals were studied. Incubations were per-
formed in 50 mi Tris-HC1 (pH = 7.4) with 0.8% bovine serum
albumin, 120 mrvi NaCI, 5 mrvi MgC12 and 45 to 150 pg of
membrane protein. Five to 25 pg of '251-AII (New England
Nuclear, Boston, Massachusetts, USA; sp. act. 1880 CiImg)
and varying amounts of unlabelled All (10° to 10—8 M) (Sigma
Chemical Co., St. Louis, Missouri, USA) were added to the
incubation tubes to perform binding inhibition studies. Nonspe-
cific binding was determined in the presence of 0.3 LM
unlabelled All. Total incubation volume was 300 l. Binding
studies were performed at 22°C for 60 minutes, at which time
binding was stopped by addition of 4 ml of iced phosphate
buffered—saline (PBS) to the incubation tube. Receptor bound
All was separated from free All on millipore filters (HAWP
0.45 sm, Millipore Corp., Bedford, Massachusetts, USA) and
rinsed with 4 ml of PBS. Receptor bound radioactivity trapped
on filters was counted on a Searle gamma counter (G. D. Searle
and Co., Skokie, Illinois, USA) with 63% counting efficiency.
All studies were performed in triplicate, and binding was
corrected for nonspecific binding (<20% of total binding).
Specific binding was 4 to 6% of total radioactivity. Binding
constants were determined by Scatchard analysis of binding
data [17] after fitting data to a line by using the least squares
method [18]. Protein concentration of the receptor suspension
was determined by a modification of the method of Lowry et al
[19].
Four separate comparisons were undertaken: 1) control ver-
sus 2-K, lC RVH (N = 5); 2) 2-K, lC RVH versus 2-K, 1C
RVH and one dose of CEI (N = 3); 3)2-K, 1C RVH versus 2-K,
1C RVH and 3 days of CEI (N = 5); and 4)2-K, 1C RVH versus
2-K, 1C RVH and unilateral nephrectomy (N = 5). Results are
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Table 1. Systolic blood pressure, plasma electrolytes, plasma renin
activity and plasma aldosterone in 2-K, IC RVH
PRA Aldo
SBP Na mEqi K ng All ng/IOO
mm Hg liter mEqlliter mi/hr ml
Control 105 4 145.3 0.6 4.12 0.11 1.4 0.5
(35) (10) (10) (10)
8.1 1.1
(12)
RVH 168 5 143.8 0.8 3.98 0.14 4.2 0.6
(31) (12) (12) (10)
9.1 1.2
(19)p <0.001 NS NS <0.001 NS
0
0 12.5 25 50
A II dose, ng
Fig. 1. Pressor dose response curves to Al! in control rats (, N = 7)
and rats with 2-K, IC RVH (, N = 10).
expressed as the mean SEM. Statistical analyses were made
by the unpaired Student's t-test except for the binding data
where the paired t-test was utilized. A P value of <0.05 was
considered statistically significant.
Results
Two to three weeks after the application of the renal artery
clip SBP was increased (Table 1). This was associated with a
threefold increase in PRA. However, plasma Na, K and aldos-
terone were comparable in control and hypertensive rats.
The pressor response to graded doses of All in control and
hypertensive rats is shown in Figure 1. The pressor response of
rats with RVH was 60% of that of control animals receiving
identical doses of All.
The pressor response to graded doses of norepinephrine in
control and hypertensive rats is shown in Table 2. Since the
pressor response of rats with 2-K, lC RVH was comparable to
control animals, the decrease in pressor sensitivity to All in
2-K, 1C RVH was specific for All and not caused by elevated
blood pressure.
To determine whether receptor occupancy with endogenous
All was the cause for the diminished pressor sensitivity to
exogenous All, rats with 2-K, lC RVH were given one dose of
the CEI captopril (Figure 2). After one dose of captopril MAP
decreased from 182 4 to 156 3 mm Hg (P < 0.001).
However, the pressor response to All remained abnormal.
Table 2. p
rats
ressor dose—response curves to norepinephrine in cont
and rats with 2-K, 1C renovascular hypertension
rol
Change in blood pressure mm HgBaseline Dose of norepinephrineblood
ng
pressure
mmHg 50 100 300 400
Control (5) 106 4 15.8 2.9 19.0 3.1 24.6 3.1 36.2 3.8
RVH (5) 154 6 18.3 2.7 25.6 3.2 29.7 3.1 40.3 3.6P 0.001 NS NS NS NS
Fig. 2. Pressor dose response curves to All in rats with 2-K, IC RVH
100 treated with blank (, N = 6) or one dose of captopril (A, N = 8). The
control group () is included from Figure 1 for comparison.
These results suggest that in our model of 2-K, lC RYH the
decreased pressor response to exogenous All cannot be attrib-
uted to receptor occupancy with endogenous hormone.
To determine whether the decrease in vascular reactivity was
caused by a decrease in binding of All to its putative receptor
we performed receptor binding studies in mesenteric artery
preparations. Steady—state binding data revealed a single class
of receptors with high binding affinity. Binding was saturable in
both control and RVH mesenteric arteries over a protein
concentration of 45 to 150 tg protein/300 d incubation volume.
Time course studies revealed maximal binding occurred be-
tween 45 and 60 minutes.
Figure 3 demonstrates total binding with increasing doses of
All. Binding of All was equal or greater by RVH than control
mesenteric arteries at each concentration of All. Scatchard
analysis revealed an increase in the total numer of binding sites
(BMAX) in RVH. The apparent equilibrium dissociation con-
stant, Kd, was similar in the two groups (Table 3). These results
suggest that All binding is increased in RVH as a result of an
increase in the number of receptors. Since All binding capacity
was increased, the decrease in pressor response to exogenous
All was caused by an abnormality distal to the interaction of
All with its receptor.
Chronic reduction of All
To determine the relationship between the increase in endog-
enous All and the postreceptor defect, Al! levels were chron-
ically reduced by two different methods. In the first series of
studies animals with RVH were treated for three days with CE!.
Numbers in parenthesis refer to number of animals in each group,
Abbreviations are: SBP, systolic blood pressure; Na, plasma sodium;
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0 1 2 3 4 5 6 7
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Fig. 3. All binding to mesenteric artery membrane fractions in control
rats (9 N = 5) and rats with 2-K, JC RVH (i, N 5).
Table 3. Angiotensin II receptor binding constants in the mesenteric







Normotensive control 91.7 6.5 1.4 0.27
2-K, IC RVH 140.8 6.3 1.3 0.10
P value <0.01 NS
A II dose, ng
Fig. 4. Pressor dose response curves to All in rats with RVH N =
5) and in rats with RVH treated with captopril for 3 days (, N = 4).
0 1 2 3 4 5 6 7
All concentration, nM
Fig. 5. All binding to mesenteric artery membrane fractions in rats
with RVH (a, N = 5) and in rats with RVH treated with captopril for 3
days (, N 5).
the decrease in pressor sensitivity to All in 2-K, 1C RVH was
mediated by a post-receptor defect.
Since converting enzyme inhibition may be associated with
alterations in Na and K balance, increases in kinins [20] and
prostaglandins [20, 21], as well as with a reduction in All, we
reduced All in additional experiments by performing unilateral









































N = 5 paired experiments, 40 rats
In the second series, animals underwent removal of the clipped
kidney and the source of the increased PRA.
Figure 4 demonstrates the effect of three days of converting
enzyme inhibition on vascular reactivity. After sustained
converting—enzyme inhibition, MAP was reduced from 149 5
(N = 5) to 125 6 (N = 4) mm Hg, P < 0.01, and the pressor
response to exogenous All was markedly enhanced. Figure 5
demonstrates the effect of sustained converting enzyme inhibi-
tion on All binding. Binding of All was equal or less in
mesenteric arteries from rats with RVH treated with captopril
at all concentrations of All. Table 4 demonstrates that chronic
(3 days) but not acute (1 dose) administration of captopril
resulted in a decrease in BMAX in mesenteric arteries from rats
with 2-K, 1C RVH. Since All pressor sensitivity increased as
All binding decreased, these results support the contention that
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Table 4. Angiotensin 11 receptor binding constants in the mesenteric




2-K, 1C RVH 105 12.7 1.07 0.27
2-K, IC RVH
3 days of captopril 83 13.3 0.82 0.12
P value <0.05 NSN = 5 paired experiments, 30 rats
2-K, 1C RVH l22 14.6 1.25 0.21
2-K, 1C RVH
I dose of captopril 128 10.9 1.15 0.27
P value NS NS
N = 3 paired experiments, 18 rats
0
0
A II dose, ng
Fig. 6. Pressor dose response curves to All in rats with RVH under-
going sham nephrectomy (, N = 6) or nephrectomy (, N 6).
rats with RVH undergoing nephrectomy, PRA was reduced
from 6.8 0.4 (N = 6) to 2.2 0.4 (N = 7) ng AI/mllhr, P <
0.001 and SBP from 171 15 (N = 7) to 111 4 (N = 6) mm
Hg, P < .005. Figure 6 demonstrates that the pressor response
to All was enhanced by nephrectomy. Figure 7 demonstrates
that binding of All was equal or less in arteries from nephrec-
tomized rats at all concentrations of All. Scatchard analysis
(Table 5) revealed a decrease in BMAX in arteries from nephrec-
tomized rats while there was no change in the apparent Kd.
These results with nephrectomy are similar to those obtained
after chronic administration of CEI and demonstrate that the
sustained reduction of All reverses the post-receptor defect of
2-K, IC RVH as manifest by a decrease in All binding in
association with an increase in All pressor sensitivity.
Discussion
Even though All mediates hypertension in the early phase of
2-K, 1C RVH, the pressor response to exogenous All is blunted
in this model of hypertension. The decrease in pressor sensi-
tivity is selective for All since we (Table 2) and others [9, 101
have shown that pressor sensitivity to norepinephrine is normal
in 2-K, IC RVH. While others have attributed the decrease in
1 2 3 4 5 6 7
A II concentration, nM
Fig. 7. All binding to mesenteric artety membrane fractions in rats
with RVH undergoing sham nephrectomy (è, N = 5) or nephrectomy(9 N 5).
Table 5. Angiotensin II receptor binding constants in the mesenteric





2-K, IC RVH Sham 136 13.4 1.67 0.25
2-K, IC RVH Nephrectomy 94 9.4 1.46 0.22
P value <0.05 NS
All pressor sensitivity to receptor occupancy with endogenous
hormone, [9, 10] the results of our study and of Schiffrin,
Thome and Genest [22] support the conclusion that the de-
crease in vascular reactivity is mediated by post-receptor
abnormalities rather than by prior occupancy or by defects in
the number of binding sites or the binding affinity of the All
receptor.
We excluded prior occupancy on the basis of the results from
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2) and from studies on All receptor binding. In contrast to
Marks et a! [9, 10] who observed an increase in All pressor
sensitivity in rats with early 2-K, 1C RVH after one dose of
CEI, we did not observe an increase in All pressor sensitivity
in 2-K, 1 C RVH (Fig. 2). There are several potential explana-
tions for the discrepancy between our results and those of
Marks et al [9, 10]. Since we did not measure circulating All
levels, it is possible that the dose of captopril was inadequate to
decrease circulating All. Alternatively, it is possible that we did
not allow sufficient time for the dissociation of All from its
receptor. Both of these explanations seem unlikely since we
utilized a higher dose of captopril than Marks et al and since
MAP decreased significantly after captopril. Another possible
explanation for the discrepancy in results is the conditions
under which All vascular reactivity were determined. Whereas
Marks et al [9, 10] determined reactivity in rats anesthetized
with pentobarbital, we studied conscious rats after recovery
from ether anesthesia. Pentobarbital anesthesia is associated
with activation of the renin angiotensin axis [23, 24]. This acute
increase in All would result in saturation of vascular All
receptors with endogenous hormone and decrease the pressor
response to exogenous All. The effect of pentobarbital on All
would be anticipated in control rats and would result in an
increase in exogenous All pressor sensitivity when endogenous
hormone levels were reduced by CEI. In the absence of
pentobarbital induced activation of the renin angiotensin axis as
occurs in the conscious rat utilized for our studies, the admin-
istration of CEI has not been found to alter exogenous All
sensitivity in control rats [14]. It is possible, therefore, that the
increase in All sensitivity in RVH after CEI noted by Marks et
a! was caused by acute pentobarbital-induced increases in All
since these investigators observed an increase in All pressor
sensitivity after CE! in control rats as well as rats with RVH.
In addition to the results after one dose of CEI, the results of
binding studies suggest that the decrease in vascular reactivity
cannot be attributed to receptor occupancy. Since the methods
utilized to prepare membrane fractions for receptor analysis
dissociate All from its putative receptor [12, 25], changes in All
binding would not be anticipated if occupancy were the cause of
vascular hyporesponsiveness. In contrast we found an increase
in All binding (Fig. 3), which we attribute to an increase in the
number of binding sites as the apparent Kd was unchanged
(Table 3). Since All binding was increased in association with
decreased reactivity, the data suggests that a post-receptor
abnormality mediated the decrease in reactivity. In support of
post-receptor hypothesis, we found that both chronic convert-
ing—enzyme inhibition and nephrectomy, maneuvers which
decrease circulating All levels, dissociated All binding from
vascular reactivity; that is, binding decreased as vascular
reactivity increased. Taken together, therefore, our data is
consistent with the conclusion that a postreceptor abnormality
mediated the decreased vascular reactivity of 2-K, IC RVH.
An unexpected finding in both our study and that of Schiffrin,
Thome and Genest [22] was the failure to observe All-induced
down regulation of receptor number in RVH. Although down
regulation often occurs in association with an increase in
peptide hormones, down regulation is not an invariable conse-
quence of an increase in All. For example, down regulation
occurs after Na depletion [12, 13] or exposure of vascular
smooth muscle cells in culture to All [26]. However, it may not
occur after the administration of low dose All to intact animals
[27] and may be prevented by K depletion [14] and possibly by
aldosterone [27, 28]. We could not attribute the lack of down
regulation in RVH to either K depletion or aldosterone excess
(Table 1). Thus, we interpret our results to indicate that the
moderate increase in PRA (and presumably All) in RVH was
not sufficient to cause down regulation. Alternatively, an event
which occurred post-binding may have prevented down regu-
lation. Similar observations have been described for insulin.
High insulin levels are often associated with a decrease in the
number of insulin receptors on target tissues. However, there
are exceptions in which hormone resistance has been associ-
ated with high insulin levels and a normal number of insulin
receptors. Down regulation has been shown to be prevented at
a post-binding site [29].
Although the increase in All did not result in down regulation
of binding sites, the increase in All or in the All receptor
complexes may have induced the postreceptor abnormality. In
this regard, both maneuvers designed to decrease circulating
levels of All resulted in a decrease in All binding (Figs. 5 and
7) and reversal of the post-receptor abnormality as manifested
by an increase in All pressor reactivity (Figs. 4 and 6). There
are several post-binding biochemical events which are con-
trolled by All and could be altered in RVH. These include the
breakdown of phosphatidlyinositol-4, 5-bisphosphate to inositol
trisphosphate, [30, 31] the mobilization of calcium release from
intracellular stores, [30, 31] the influx of extracellular calcium
[32] or the phosphorylation of myosin [33]. Further studies will
be required to determine which of these reactions is altered in
RVH.
In summary, we have demonstrated that the decrease in All
reactivity in the early phase of 2-K, 1C RVH is associated with
an increase in All receptor binding and in the number of binding
sites. Furthermore, the decrease in reactivity was reversed by
either sustained administration of CEI or by ipsilateral nephrec-
tomy. Both of these maneuvers were associated with a decrease
in All receptor binding and the number of binding sites. We
conclude that the mechanism of the decrease in All vascular
reactivity in early 2-K, 1C RVH is mediated by a post-receptor
defect and that the post-receptor defect may have been caused
by an increase in circulating All.
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